Cite
HARVARD Citation
Li, Y. et al. (2021). A multicenter analysis of treatment patterns and clinical outcomes of subsequent therapies after progression on palbociclib in HR+/HER2− metastatic breast cancer. Therapeutic advances in medical oncology. p. . [Online].